2021
DOI: 10.3390/life11121393
|View full text |Cite
|
Sign up to set email alerts
|

Physiological Doses of Hydroxytyrosol Modulate Gene Expression in Skeletal Muscle of Exercised Rats

Abstract: We tested whether physiological doses of hydroxytyrosol (HT) may alter the mRNA transcription of key metabolic genes in exercised skeletal muscle. Two groups of exercise-trained Wistar rats, HTlow and HTmid, were supplemented with 0.31 and 4.61 mg/kg/d of HT, respectively, for 10 weeks. Another two groups of rats were not supplemented with HT; one remained sedentary and the other one was exercised. After the experimental period, the soleus muscle was removed for qRT-PCR and western blot analysis. The consumpti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…Checking the HbA1C value every 3-6 months can be used for glycaemic monitoring, with a value of less than 7% indicating that glycaemic stability has been maintained (11). The American Diabetes Association (ADA) provided a guideline for the treatment of diabetes with obesity in 2015, stating that suitable glycaemic-lowering drugs in diabetic cases with obesity are sodium-glucose cotransporter-2 (SGLT2) inhibitors and GLP-1 receptor agonists (GLP-1 RA) (12), which may lead to an average weight loss of about 2-3 kg when used at approved doses (13). SGLT2 inhibitors (dapagliflozin) are thought to help obese people lose weight and lower their systolic blood pressure (14).…”
Section: Introductionmentioning
confidence: 99%
“…Checking the HbA1C value every 3-6 months can be used for glycaemic monitoring, with a value of less than 7% indicating that glycaemic stability has been maintained (11). The American Diabetes Association (ADA) provided a guideline for the treatment of diabetes with obesity in 2015, stating that suitable glycaemic-lowering drugs in diabetic cases with obesity are sodium-glucose cotransporter-2 (SGLT2) inhibitors and GLP-1 receptor agonists (GLP-1 RA) (12), which may lead to an average weight loss of about 2-3 kg when used at approved doses (13). SGLT2 inhibitors (dapagliflozin) are thought to help obese people lose weight and lower their systolic blood pressure (14).…”
Section: Introductionmentioning
confidence: 99%
“…The results suggest that moderate aerobic exercise with a high-protein diet can alleviate OA symptoms and articular cartilage degradation by reducing inflammation and oxidative stress. Moreover, the paper by Casuso et al [5] a high physiological dose of a powerful antioxidant (i.e., the polyphenol hydroxytirosol) can enhance skeletal muscle mRNA transcripts of the glucose oxidation pathway but hampers the protein translation. Thus highlighting that caution should be taken when analyzing the effects of nutritional interventions on muscle mRNA levels.…”
mentioning
confidence: 99%